Related Experiment Video
Updated: Mar 25, 2026

Production of High-Titer Recombinant Newcastle Disease Virus from Allantoic Fluid
Published on: May 25, 2022
Viral persistence in colorectal cancer cells infected by Newcastle disease virus
Suet-Lin Chia, Khatijah Yusoff, Norazizah Shafee1
1Department of Microbiology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang 43400, Malaysia. nshafee@upm.edu.my.
Background:
Newcastle disease virus (NDV), a single-stranded RNA virus of the family Paramyxoviridae, is a candidate virotherapy agent in cancer treatment. Promising responses were observed in clinical studies. Despite its high potential, the possibility of the virus to develop a persistent form of infection in cancer cells has not been investigated. Occurrence of persistent infection by NDV in cancer cells may cause the cells to be less susceptible to the virus killing. This would give rise to a population of cancer cells that remains viable and resistant to treatment.
Results:
During infection experiment in a series of colorectal cancer cell lines, we adventitiously observed a development of persistent infection by NDV in SW480 cells, but not in other cell lines tested. This cell population, designated as SW480P, showed resistancy towards NDV killing in a re-infection experiment. The SW480P cells retained NDV genome and produced virus progeny with reduced plaque forming ability.
Conclusion:
These observations showed that NDV could develop persistent infection in cancer cells and this factor needs to be taken into consideration when using NDV in clinical settings.
Insights
Newcastle disease virus (NDV) can establish persistent infections in cancer cells, leading to treatment resistance. This finding is crucial for optimizing NDV virotherapy strategies in clinical settings.
Area of Science:
- Oncology
- Virology
- Cancer Therapeutics
Background:
- Newcastle disease virus (NDV) is a promising candidate for cancer virotherapy.
- Clinical studies have shown promising responses to NDV treatment.
- The potential for NDV to establish persistent infections in cancer cells remains unexplored.
Purpose of the Study:
- To investigate the development of persistent Newcastle disease virus (NDV) infection in cancer cells.
- To determine if persistent NDV infection impacts cancer cell susceptibility to viral killing.
Main Methods:
- Infection of colorectal cancer cell lines with NDV.
- Observation of adventitious persistent infection in SW480 cells.
- Re-infection experiments to assess viral resistance in persistently infected cells.
Main Results:
- A persistent NDV infection was observed in SW480 cells, designated SW480P.
- SW480P cells demonstrated resistance to NDV-induced cell killing.
- Persistently infected SW480P cells retained the NDV genome and produced progeny with reduced plaque-forming ability.
Conclusions:
- Newcastle disease virus (NDV) can establish persistent infections in cancer cells.
- Persistent NDV infection can lead to cancer cell resistance to virotherapy.
- Consideration of persistent infection is essential for effective clinical application of NDV.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Retrovirus Life Cycles
Viral Recombination

